禮來股價波動與新藥實驗結果分析

禮來(LLY.N)美股盤前跌幅擴大至11%，實驗顯示，禮來口服藥物Orforglipron平均減重11.2%。

最新市場快訊

12:00:11

澤連斯基強調和平進程需烏克蘭參與

11:51:41

美國CPI數據的重要性與市場關注

11:38:52

廣東省基孔肯雅熱疫情現狀與防控措施分析

11:29:49

北京新房與二手房網籤數據概覽

11:20:38

比特幣市場動態分析

::: Capital Securities Capital Inv. Cons. Capital Insurance Capital Asset Mgmt. Capital HK

Navigation About Governance Sustainable Fair Treatment Anti-Fraud Stakeholders Disclaimer Security Friendly Career ESG Initiatives

Futures Corporation:(02)2700-2888
B1, No. 97, Section 2, Dunhua South Road, Taipei City
Taichung Branch:(04)2319-9909
3F-6, No. 633, Sec. 2, Taiwan Blvd, Xitun Dist, Taichung City